These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31205244)

  • 1. Dilemmas With Rotavirus Vaccine: The Neonate and Immunocompromised.
    Chiu M; Bao C; Sadarangani M
    Pediatr Infect Dis J; 2019 Jun; 38(6S Suppl 1):S43-S46. PubMed ID: 31205244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccination in the neonatal intensive care units: where are we? A rapid review of recent evidence.
    Sicard M; Bryant K; Muller ML; Quach C
    Curr Opin Pediatr; 2020 Feb; 32(1):167-191. PubMed ID: 31851055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.
    Thrall S; Doll MK; Nhan C; Gonzales M; Perreault T; Lamer P; Quach C
    Vaccine; 2015 Sep; 33(39):5095-102. PubMed ID: 26296493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recommendations for vaccination against ROTAvirus in PREMature newborns (ROTAPREM)].
    Álvarez Aldeán J; Ares Segura S; Díaz González C; Montesdeoca Melián A; García Sánchez R; Boix Alonso H; Moreno-Pérez D;
    An Pediatr (Engl Ed); 2019 Sep; 91(3):205.e1-205.e7. PubMed ID: 31288982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014.
    Vesikari T; Van Damme P; Giaquinto C; Dagan R; Guarino A; Szajewska H; Usonis V
    Pediatr Infect Dis J; 2015 Jun; 34(6):635-43. PubMed ID: 25860532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccines: viral shedding and risk of transmission.
    Anderson EJ
    Lancet Infect Dis; 2008 Oct; 8(10):642-9. PubMed ID: 18922486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data.
    Banajeh SM; Abu-Asba BA
    BMC Infect Dis; 2015 Oct; 15():418. PubMed ID: 26464210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.
    Markkula J; Hemming-Harlo M; Salminen MT; Savolainen-Kopra C; Pirhonen J; Al-Hello H; Vesikari T
    Infect Dis (Lond); 2017 May; 49(5):388-395. PubMed ID: 28067093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of herd immunity and sustained impact of rotavirus vaccination on the reduction of rotavirus-related medical encounters among infants from 2006 through 2011 in the United States.
    Mast TC; Wang FT; Su S; Seeger JD
    Pediatr Infect Dis J; 2015 Jun; 34(6):615-20. PubMed ID: 25831421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human rotavirus vaccine on severe diarrhea in African infants.
    Madhi SA; Cunliffe NA; Steele D; Witte D; Kirsten M; Louw C; Ngwira B; Victor JC; Gillard PH; Cheuvart BB; Han HH; Neuzil KM
    N Engl J Med; 2010 Jan; 362(4):289-98. PubMed ID: 20107214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal Mass Vaccination Against Rotavirus: Indirect Effects on Rotavirus Infections in Neonates and Unvaccinated Young Infants Not Eligible for Vaccination.
    Prelog M; Gorth P; Zwazl I; Kleines M; Streng A; Zlamy M; Heinz-Erian P; Wiedermann U
    J Infect Dis; 2016 Aug; 214(4):546-55. PubMed ID: 27190178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Parashar UD; Alexander JP; Glass RI;
    MMWR Recomm Rep; 2006 Aug; 55(RR-12):1-13. PubMed ID: 16902398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of rotavirus vaccination in Germany: rotavirus surveillance, hospitalization, side effects and comparison of vaccines.
    Uhlig U; Kostev K; Schuster V; Koletzko S; Uhlig HH
    Pediatr Infect Dis J; 2014 Nov; 33(11):e299-304. PubMed ID: 24911897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
    Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
    Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.